Methimazole Dosing Chart Based on Lab Severity
For adults with Graves' disease, start with 15 mg daily for mild hyperthyroidism, 30-40 mg daily for moderate disease, and 60 mg daily for severe hyperthyroidism, all given as a single daily dose. 1
Adult Dosing Algorithm
| Disease Severity | Free T4 Level | Initial Daily Dose | Maintenance Dose |
|---|---|---|---|
| Mild | 1.5-2x upper limit normal | 10-15 mg once daily | 5-10 mg daily |
| Moderate | 2-3x upper limit normal | 30-40 mg once daily | 5-10 mg daily |
| Severe | >3x upper limit normal | 60 mg once daily | 5-15 mg daily |
Key Dosing Principles
Give methimazole as a single daily dose - this improves compliance compared to divided dosing and is equally effective even in severe hyperthyroidism 2. The FDA label specifies divided dosing, but guideline evidence supports once-daily administration based on superior adherence data.
Titrate down by 50% once euthyroid - when thyroid hormones normalize (typically 4-8 weeks), reduce the dose by approximately half to maintain euthyroid status 2. Avoid "block and replace" regimens (continuing high-dose methimazole plus levothyroxine) as meta-analyses show higher adverse event rates 2.
Pediatric Dosing Algorithm
| Age Group | Standard Dose | Severe Disease Dose |
|---|---|---|
| Infants | 1.25 mg daily | 1.9-2.5 mg daily |
| 1-5 years | 2.5-5 mg daily | 3.75-10 mg daily |
| 5-10 years | 5-10 mg daily | 7.5-20 mg daily |
| 10-18 years | 10-20 mg daily | 15-40 mg daily |
Weight-based dosing: 0.2-0.5 mg/kg/day is the typical range, with 0.1-1.0 mg/kg/day for the full spectrum 2. For severe biochemical hyperthyroidism, use doses 50-100% higher than standard 2.
Critical Management Points
Pre-Treatment Requirements
- Obtain baseline CBC with differential and liver function tests (bilirubin, transaminases, alkaline phosphatase) 2
- Verify negative pregnancy test within 48 hours if considering radioiodine as alternative 2
When to Pretreat Before Radioiodine
Patients with free T4 >5 ng/dL (60 pmol/L) or total T4 >20 μg/dL (200 nmol/L) should receive methimazole plus beta-blockade until thyroid hormones normalize before radioiodine therapy 2. This prevents thyroid storm from radiation-induced thyroiditis.
Monitoring Strategy
- Check free T4 and total T3 at 4-6 week intervals initially 2
- TSH remains suppressed for weeks after achieving euthyroidism, so interpret cautiously 2
- Once stable, monitor every 2-3 months 2
Common Pitfalls to Avoid
Don't underdose severe disease - Recent data shows patients with severe initial hyperthyroidism reach euthyroidism as quickly as mild cases when given appropriately higher doses, though they experience more thyroid function lability 3. They need more frequent monitoring but not necessarily longer time to control.
Don't use propylthiouracil except in specific situations - Methimazole should be used in virtually every patient except: first trimester pregnancy, thyroid storm, or minor methimazole reactions when radioiodine/surgery refused 2. PTU carries unacceptable hepatotoxicity risk, particularly in children (1 in 2000-4000 risk of liver failure) 2.
Stop immediately for warning symptoms - Patients must discontinue methimazole and contact physician immediately for: fever, sore throat, rash, jaundice, dark urine, joint pain, or abdominal pain 2. Check CBC for agranulocytosis and LFTs for hepatotoxicity.
Pregnancy Considerations
- First trimester: Switch to propylthiouracil due to methimazole embryopathy risk 2
- Second/third trimester: Switch back to methimazole due to PTU hepatotoxicity risk 2
- Keep free T4 at or slightly above upper limit of normal range 2
The evidence strongly supports using adequate initial doses based on biochemical severity, with the understanding that higher doses for severe disease don't delay time to euthyroidism but do require closer monitoring for the increased lability these patients experience 3.